What if measuring biological age became clinically useful?
Two people born on the same day can age very differently. Researchers have built 'clocks' that estimate biological age from molecular signals in the body. The big question is whether these numbers can guide real medical decisions, or whether they are still mostly research tools.
⚠ This is a thought experiment. It explores a possibility; it does not report a result.
Original illustration — speculative and artistic, not a depiction of a real device, patient or result.
What exists today
Scientists have developed several ways to estimate biological age. The best known are epigenetic clocks, which use patterns of chemical tags called DNA methylation. Others combine blood test results, physical measures or protein levels. Some consumer companies sell biological age tests directly to the public. However, no biological age test is currently a standard part of routine medical care, and major health agencies do not use one to make individual treatment decisions. The US National Institute on Aging supports research into better aging biomarkers precisely because good, validated ones are still needed.
What has been demonstrated
In 2013, researcher Steve Horvath published an epigenetic clock that estimated age across many human tissues and cell types. Since then, newer clocks have been trained not only to match calendar age but to predict health outcomes. In large research cohorts, people whose clocks run 'fast' relative to their calendar age have, on average, higher risks of illness and death. That is a group-level association, which is useful for research. It has not shown that an individual's result reliably predicts their personal future, or that changing a clock score through a lifestyle change or drug improves health.
What remains difficult
Different clocks can give the same person different answers, and results can shift with the lab, sample type and even time of day. Many clocks were built mainly using data from particular populations, which may limit how well they apply to others. The biggest issue is that a clock measures a correlate of aging, not necessarily a cause. If a treatment lowers a clock score, it is unclear whether the person is actually healthier or whether the treatment simply altered the markers. Without that link, a clock is a weak guide for decisions, and people could be falsely reassured or needlessly worried.
What would change if it worked
A trustworthy measure of biological age could help researchers run shorter trials of interventions aimed at aging, since waiting decades to measure lifespan is impractical. Doctors might use it alongside other information to spot people at higher risk and prioritise prevention. It could also help test whether lifestyle programmes or medicines slow aspects of aging. But an unreliable test used widely could do harm, pushing people toward expensive products or unnecessary tests. The value would depend on accuracy, clear action steps and fair access, rather than on the appeal of a single number.
What evidence would convince us
Convincing evidence would include consistent results when the same person is tested repeatedly, agreement across labs, and strong predictive performance in diverse populations beyond the data used to build the clock. Most important would be randomised trials showing that an intervention which changes the clock also improves outcomes people care about, such as fewer illnesses, better function or longer healthy life. Regulators and medical societies would need to agree on how a result should change care. Until then, an impressive correlation in a research paper is a promising starting point, not proof that a biological age test is ready for the clinic.
If a biological age test were offered to you today, what would you do?
Polls measure reader opinion for fun and discussion. They are not scientific evidence.
If your biological age were measured as older than your calendar age, what would you want to happen next — and what evidence would you need first?
Try it hands-on:
Play Biotech Vocabulary Challenge →Related reporting
LongevityCan We Slow Aging? A Field Guide to Evidence, Hype, and Hard Questions
Longevity claims are everywhere, but human evidence is thin. This field guide sorts the most popular anti-ageing ideas by what has been shown in animals, what has been tested in people, and what nobody knows yet.
LongevityThe Longevity Dashboard: Which Health Measures Are Useful, and Which Are Still Experimental?
Some longevity metrics, like blood pressure, are backed by decades of evidence and clear actions. Others, like consumer biological-age tests, are promising research tools whose meaning for individuals is not yet settled.
LongevityThe Cell Health Frontier: Senescence, Mitochondria, and the Search for Better Healthspan
Some problems of ageing may start inside individual cells. This explainer tours senescence and mitochondria, from striking mouse results to small, mixed human trials, and explains why no therapy is yet approved to treat ageing.
Sources
- DNA methylation age of human tissues and cell types (Horvath, 2013) — PubMedpubmed.ncbi.nlm.nih.gov
